Calculating The Intrinsic Value Of Yuhan Corporation (KRX:000100)
Dec 21
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedDec 21, 2024
DataAggregated Company Financials
Companies102
- 7D-1.7%
- 3M-15.4%
- 1Y0.1%
- YTD-8.0%
Over the last 7 days, the Pharma industry has dropped 1.7%, driven by a pullback from Yuhan of 7.9%. Meanwhile, Sam Chun Dang Pharm actually outperformed within the industry, gaining 16% in the last week. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 35% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Dec 2024 | ₩51.7t | ₩29.4t | ₩989.8b | 12.7x | 52.2x | 1.8x |
| Tue, 19 Nov 2024 | ₩52.7t | ₩28.8t | ₩853.3b | 14.2x | 61.7x | 1.8x |
| Thu, 17 Oct 2024 | ₩63.3t | ₩28.7t | ₩833.2b | 16x | 76x | 2.2x |
| Sat, 14 Sep 2024 | ₩57.2t | ₩28.8t | ₩836.8b | 15.1x | 68.4x | 2x |
| Mon, 12 Aug 2024 | ₩54.2t | ₩28.5t | ₩768.0b | 14.8x | 70.5x | 1.9x |
| Wed, 10 Jul 2024 | ₩54.4t | ₩28.4t | ₩762.2b | 13.5x | 71.3x | 1.9x |
| Fri, 07 Jun 2024 | ₩53.8t | ₩30.2t | ₩909.1b | 13.4x | 59.2x | 1.8x |
| Sun, 05 May 2024 | ₩53.9t | ₩29.7t | ₩942.4b | 17.4x | 57.2x | 1.8x |
| Tue, 02 Apr 2024 | ₩55.9t | ₩29.4t | ₩922.9b | 18.1x | 60.6x | 1.9x |
| Thu, 29 Feb 2024 | ₩53.4t | ₩29.6t | ₩593.1b | 20.3x | 90.1x | 1.8x |
| Sat, 27 Jan 2024 | ₩51.7t | ₩29.6t | ₩592.3b | 22.6x | 87.3x | 1.7x |
| Mon, 25 Dec 2023 | ₩52.3t | ₩29.6t | ₩588.2b | 21.7x | 88.9x | 1.8x |
| Wed, 22 Nov 2023 | ₩50.0t | ₩29.4t | ₩652.4b | 17.8x | 76.6x | 1.7x |
| Fri, 20 Oct 2023 | ₩45.6t | ₩29.3t | ₩683.3b | 16x | 66.8x | 1.6x |
| Sun, 17 Sep 2023 | ₩52.6t | ₩29.3t | ₩683.3b | 17x | 77x | 1.8x |
| Tue, 15 Aug 2023 | ₩53.1t | ₩28.8t | ₩899.2b | 23.5x | 59x | 1.8x |
| Thu, 13 Jul 2023 | ₩45.6t | ₩28.8t | ₩899.2b | 19.7x | 50.7x | 1.6x |
| Sat, 10 Jun 2023 | ₩48.1t | ₩28.9t | ₩908.1b | 22.6x | 53x | 1.7x |
| Mon, 08 May 2023 | ₩48.6t | ₩28.5t | ₩602.7b | 21.3x | 80.7x | 1.7x |
| Wed, 05 Apr 2023 | ₩46.4t | ₩28.5t | ₩602.8b | 19.7x | 76.9x | 1.6x |
| Fri, 03 Mar 2023 | ₩43.8t | ₩27.7t | ₩743.5b | 20.3x | 58.9x | 1.6x |
| Sun, 29 Jan 2023 | ₩45.6t | ₩27.7t | ₩743.5b | 19.9x | 61.3x | 1.6x |
| Tue, 27 Dec 2022 | ₩46.8t | ₩28.0t | ₩770.2b | 20.8x | 60.7x | 1.7x |
| Thu, 24 Nov 2022 | ₩44.8t | ₩27.5t | ₩679.5b | 20.9x | 65.9x | 1.6x |
| Sat, 22 Oct 2022 | ₩40.9t | ₩27.2t | ₩694.8b | 20.2x | 58.8x | 1.5x |
| Mon, 19 Sep 2022 | ₩46.9t | ₩27.5t | ₩720.9b | 21.1x | 65x | 1.7x |
| Wed, 17 Aug 2022 | ₩51.8t | ₩26.7t | ₩475.9b | 22.9x | 108.8x | 1.9x |
| Fri, 15 Jul 2022 | ₩50.0t | ₩26.7t | ₩475.9b | 22.1x | 105x | 1.9x |
| Sun, 12 Jun 2022 | ₩52.2t | ₩26.7t | ₩477.5b | 23.4x | 109.3x | 2x |
| Tue, 10 May 2022 | ₩53.3t | ₩26.1t | ₩674.3b | 26x | 79x | 2x |
| Thu, 07 Apr 2022 | ₩56.4t | ₩26.1t | ₩675.6b | 26.5x | 83.5x | 2.2x |
| Sat, 05 Mar 2022 | ₩55.2t | ₩25.0t | ₩934.5b | 24.1x | 59.1x | 2.2x |
| Mon, 31 Jan 2022 | ₩50.9t | ₩25.0t | ₩934.5b | 21.3x | 54.5x | 2x |
| Wed, 29 Dec 2021 | ₩60.8t | ₩25.0t | ₩934.5b | 24.7x | 65.1x | 2.4x |
Price to Earnings Ratio
65.1x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 52.2x which is lower than its 3-year average PE of 70.6x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -3.69% | |
| Healthcare | -4.04% | |
| Pharma | -1.75% | |
| Pharma | -1.75% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A000250 Sam Chun Dang Pharm | ₩118.10k | 15.8% +₩374.4b | 66.8% | PE537.5x | |
| A214370 Caregen | ₩26.95k | 10.9% +₩129.8b | 0% | PE36.9x | |
| A000640 Dong-A Socio Holdings | ₩113.20k | 12.9% +₩80.6b | 13.2% | PE12.8x | |
| A068760 Celltrion Pharm | ₩59.80k | 2.9% +₩70.4b | -30.5% | n/a | |
| A200670 Humedix | ₩42.00k | 18.6% +₩68.0b | 21.4% | n/a |
